David A. Siegel Anika Therapeutics, Inc. Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 19,083 shares of ANIK stock, worth $180,525. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,083
Previous 20,783
8.18%
Holding current value
$180,525
Previous $312,000
35.58%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding ANIK
# of Institutions
109Shares Held
11.5MCall Options Held
0Put Options Held
0-
Trigran Investments, Inc.2.04MShares$19.3 Million4.01% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$15.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA779KShares$7.37 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX623KShares$5.89 Million0.0% of portfolio
-
Opaleye Management Inc. Boston, MA589KShares$5.57 Million1.49% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $138M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...